ClinicalTrials.gg
CompletedNCT02391870Updated Apr 6, 2020

The Staying Well Study: An Open Trial of Mindfulness-Based Cognitive Therapy for the Prevention of Perinatal Depression

An interventional study of MBCT-PD in Pregnancy, Depression and Postpartum Depression, sponsored by University of Colorado, Boulder. Completed at 4 sites in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-04-06.

Sponsored by University of Colorado, Boulder · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
49
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

Pregnant women with histories of depression are at high risk of depressive relapse during the perinatal period, and options for relapse prevention are limited. Mindfulness-based cognitive therapy (MBCT) has strong evidence among general populations but has not been studied among at risk pregnant women.

This study is the first phase of a multi-phase project adapting MBCT for perinatal women (MBCT-PD). It is being conducted in a collaboration between the University of Colorado, Emory University, and Kaiser Permanente at Colorado and Georgia.

Read the detailed description

Mindfulness-based cognitive therapy (MBCT) represents one of the most important recent developments in the effort to prevent recurrent depression. Explicitly designed to modify core underlying vulnerability factors among recovered individuals with histories of depression, MBCT may have high applicability to the prevention of perinatal depression (PD).

During this phase of the project the investigators will employ an iterative process to develop, within routine obstetric clinical settings, the MBCT-PD program across a two-center open trial of pregnant women at high risk of perinatal depression. During this phase, the investigators will modify the standard MBCT approach to be sensitive and specific to women at high risk of perinatal depressive relapse or recurrence based on previous history of depression and will address the following aims:

  • Specific Aim 1: To examine the feasibility of MBCT-PD with respect to identification and enrollment of women at-risk of perinatal depression based on a history of depression.
  • Specific Aim 2: To examine the engagement of women with the MBCT-PD approach with respect to retention, completion of daily practice assignments, and satisfaction
  • Specific Aim 3: To examine the clinical outcomes including change in depression symptom levels and rates of relapse/recurrence over the course of the intervention and through a 6-month postpartum follow-up.
02

Conditions studied

  • Pregnancy
  • Depression
  • Postpartum Depression

Keywords

  • depression
  • mindfulness
  • pregnancy
  • prevention
  • cognitive behavioral therapy
03

In context

Depression

8,240 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's enrollment of 49 is below the median of 84 across 6,869 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

University of Colorado, Boulder is the lead sponsor of 88 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Pregnant up to 32 weeks gestation
  • Meeting criteria for prior depression
  • Failure to meet criteria for a diagnosis of MDD in the last two months
  • Available for group intervention scheduled meetings

Exclusion criteria

Exclusion Criteria:

  • Presence of schizophrenia or schizoaffective disorder
  • Presence of bipolar disorder or current psychosis
  • Presence of organic mental disorder or pervasive developmental delay
  • Presence of current eating disorder
  • Presence of current substance abuse or dependence
  • Presence of antisocial, borderline, or schizotypal personality disorder
  • Presence of imminent suicide or homicide risk
  • Presence of any other axis I or II disorders that necessitate priority treatment not provided by the study protocol
  • Women with any medical conditions that would preclude participation, including high-risk pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
49 participants (actual)

Study arms

  • Experimental
    MBCT-PD

    Mindfulness-based cognitive therapy adapted for perinatal women (MBCT-PD)

    Behavioral: MBCT-PD

Interventions

  • BehavioralMBCT-PD

    Using an iterative process, the investigators modified MBCT to include a focus on perinatal depression (MBCT-PD). The modifications took into account developmental processes associated with the perinatal period, characteristics and correlates of perinatal depression, and the physical aspects of pregnancy.

06

What researchers measure

Primary outcomes

  1. Engagement

    Engagement is operationalized in-part as class attendance, with completion is defined as attendance at a minimum of four classes, and daily home practice recorded daily as the number of times of practice and type of practice, which are classified as either formal or informal practice.

    Time frame: Up to 8 weeks

  2. Client Satisfaction

    Participant satisfaction will be evaluated by the CSQ-8, which is designed to yield a homogeneous estimate of general satisfaction with services. An exit interview also will be completed at 6-months postpartum.

    Time frame: Up to 8 weeks

  3. MBCT-PD Adherence Scale (MBCT-PD-AS)

    Treatment fidelity will be assessed to provide checks on the adequacy of treatment implementation, using the MBCT-PD Adherence Scale.

    Time frame: Up to 8 weeks

  4. Depressive Relapse Status: Longitudinal Interval Follow-up Evaluation (LIFE)

    Rate of depressive relapse and time to relapse will be assessed using the LIFE, which provides a retrospective assessment of relapse or recurrence based on a semi-structured interview according to DSM-IV-TR diagnostic criteria.

    Time frame: Up to 6 months postpartum

  5. Change in Edinburgh Postpartum Depression Scale (EPDS)

    Change in the severity of depressive symptoms will be evaluated by the Edinburgh Postpartum Depression Scale (EPDS), which is the most widely used self-report measure of antenatal and postpartum depression.

    Time frame: Up to 6 months postpartum

07

Study locations

4 sites
  • University of Colorado Boulder
    Boulder, Colorado 80309, United States
  • Kaiser Permanente Colorado
    Denver, Colorado 80234, United States
  • Emory University
    Atlanta, Georgia 30322, United States
  • Kaiser Permanente
    Atlanta, Georgia 30328, United States
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Nov 2008, a primary completion of Mar 2011 and a completion of Mar 2011. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 12, 2015
First posted
Mar 18, 2015
Start
Nov 2008
Primary completionActual
Mar 2011
CompletionActual
Mar 2011
Last update
Apr 6, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 6, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02391870
Lead sponsor
University of Colorado, Boulder
Responsible party
Sona Dimidjian (Professor and Director, University of Colorado, Boulder) — Principal investigator
First posted
Mar 18, 2015
Start date
Nov 2008
Primary completion
Mar 2011
Completion
Mar 2011
Last update
Apr 6, 2020

Study contacts

Sona Dimidjian, PhD
principal investigator · University of Colorado, Boulder
Sherryl Goodman, PhD
principal investigator · Emory University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion